Market Outlook
The global Cardiac Stent market size was valued at USD 7362.5 million in 2022 and is forecast to a readjusted size of USD 11740 million by 2029 with a CAGR of 6.9% during review period.
A Cardiac Stent (also called coronary stent) is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI).
The global PCI device market is projected to gain growth on the back of the prevalence of cardiovascular diseases and the aging process. The global Cardiac Stent market is forecasted to keep the trend.
As the technology of Cardiac Stent is relatively mature and the downstream market, especially for Angina application is growing fast, so there are lots of enterprises in the Cardiac Stent market. The Cardiac Stent market competition will be still intense. Abbott Vascular is the leading manufacturer in the global Cardiac Stent market with the market share of 24.95%, in terms of revenue, followed by Boston Scientific, Medtronic, Terumo (ESSEN), Lepu Medical, MicroPort, Biosensors, B.Braun, Atrium Medical, Biotronik, and SINOMED. These leading 11 companies accounted for 96% of the market share in 2019.
This report is a detailed and comprehensive analysis for global Cardiac Stent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cardiac Stent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cardiac Stent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cardiac Stent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cardiac Stent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiac Stent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiac Stent market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Abbott Vascular
Boston Scientific
Medtronic
Terumo (ESSEN)
Lepu Medical
MicroPort
Biosensors
B.Braun
Atrium Medical
Biotronik
SINOMED
Segmentation By Type
Bare-metal Stent (BMS)
Drug-eluting Stent (DES)
Bioresorbable Vascular Scaffold (BVS)
Segmentation By Application
Angina
Myocardial Infarction
Other Disease
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the cardiac stent market in 2025?
The cardiac stent market in 2025 is expected to be strengthened by technological advancements, such as drug-eluting stents and bioresorbable stents. These innovations improve patient outcomes and reduce the risk of restenosis, leading to increased adoption. Additionally, the aging global population and rising incidence of cardiovascular diseases will drive market demand.
What weaknesses might the cardiac stent market face in 2025?
High costs associated with advanced stents could limit accessibility, especially in emerging markets. Furthermore, complications related to stent procedures, such as thrombosis or restenosis, can deter patients and healthcare providers. Regulatory hurdles and slow product approvals can also delay market expansion.
What opportunities exist for the cardiac stent market in 2025?
There is significant growth potential in emerging markets, where rising healthcare infrastructure and awareness are creating new demand. Additionally, innovations in personalized medicine and the growing trend toward minimally invasive procedures offer opportunities for new product development and expansion. Collaboration with digital health technologies could also open up avenues for more efficient post-procedure monitoring and patient care.
What threats could impact the cardiac stent market in 2025?
Increased competition from alternative treatments, such as coronary artery bypass grafting (CABG) or drug therapies, may challenge the dominance of stent procedures. Additionally, rising concerns over long-term stent safety and the potential for stent thrombosis could negatively affect market growth. Economic downturns or healthcare budget cuts in certain regions could also limit the adoption of new stent technologies.
Market PESTEL Analysis
What political factors will influence the cardiac stent market in 2025?
Government regulations and policies related to medical devices and healthcare spending will significantly impact the cardiac stent market. Healthcare reforms, reimbursement policies, and approvals for new technologies will play a crucial role in market expansion. Political stability in key regions will also influence the ability of companies to operate smoothly.
How will economic factors affect the cardiac stent market in 2025?
Economic growth in developing countries will drive demand for cardiac stents as healthcare access improves. However, the high cost of advanced stents may limit their adoption in regions with economic constraints. Economic downturns or shifts in healthcare spending could impact the affordability and accessibility of these devices.
What social factors will shape the cardiac stent market in 2025?
An aging population and increasing prevalence of cardiovascular diseases will drive demand for cardiac stents. Additionally, greater awareness of heart health and technological advancements in healthcare will encourage patients to seek out advanced treatments. However, societal concerns about medical device safety and the preference for alternative treatments could influence market dynamics.
What technological factors will influence the cardiac stent market in 2025?
Technological advancements in stent design, such as drug-eluting and bioresorbable stents, will continue to enhance market growth. Innovations in minimally invasive procedures and digital health solutions for post-procedure care will further propel the market. However, the pace of innovation and the cost of research and development will be critical factors to watch.
What environmental factors will affect the cardiac stent market in 2025?
Sustainability and environmental concerns around medical device production and waste management are becoming increasingly important. Manufacturers will face pressure to adopt greener practices and reduce the environmental footprint of their products. Regulatory standards around the use of materials in stents and their disposal could impact manufacturing costs and processes.
What legal factors will influence the cardiac stent market in 2025?
Strict regulatory standards for medical devices, particularly stents, will affect market entry and product approval. Compliance with safety standards and clinical trial regulations will be essential for manufacturers. Intellectual property rights and patent expirations may also influence competition and market dynamics in the stent industry.
Market SIPOC Analysis
Who are the suppliers in the cardiac stent market in 2025?
Suppliers in the cardiac stent market include raw material providers (such as metal alloys, polymers, and drug coatings), stent manufacturers, and technology developers for advanced stent designs like drug-eluting or bioresorbable stents. Additionally, contract manufacturers and suppliers of specialized equipment for stent production play a key role.
What inputs are required for the cardiac stent market in 2025?
The primary inputs required for the cardiac stent market are raw materials like stainless steel, cobalt-chromium, platinum, and biodegradable polymers. Other critical inputs include advanced technology for drug coating, biocompatible materials for stent construction, and highly skilled labor for manufacturing processes. Regulatory expertise and capital investment are also essential.
Who are the process owners in the cardiac stent market in 2025?
Process owners in the cardiac stent market are stent manufacturers, regulatory bodies, research and development teams, and healthcare providers. Manufacturers oversee the production process, while R&D teams drive innovation. Regulatory bodies are responsible for ensuring compliance with medical device standards, and healthcare providers administer stent treatments to patients.
What are the outputs of the cardiac stent market in 2025?
The primary output of the cardiac stent market is the production of stents, including drug-eluting stents, bare-metal stents, and bioresorbable stents. These stents are sold to hospitals, clinics, and cardiologists for implantation in patients. Additionally, post-procedure monitoring services and data related to stent performance can be outputs.
Who are the customers in the cardiac stent market in 2025?
Customers in the cardiac stent market include hospitals, medical clinics, cardiologists, and healthcare systems. Patients suffering from coronary artery disease or other cardiovascular conditions are indirect customers, as they rely on healthcare providers to recommend and implant the appropriate stents. Insurance companies also play a role in covering costs for patients.
Market Porter's Five Forces
What is the threat of new entrants in the cardiac stent market in 2025?
The threat of new entrants in the cardiac stent market is moderate. High capital investment, complex manufacturing processes, and strict regulatory requirements make it difficult for new players to enter the market. Established companies with strong brand recognition and distribution networks also pose significant barriers to entry.
How strong is the bargaining power of suppliers in the cardiac stent market in 2025?
The bargaining power of suppliers is moderate to high. Key materials like specialized metals and polymers are sourced from a limited number of suppliers, which can give them some influence over pricing. However, many manufacturers have developed long-term relationships and may have alternative sourcing options, which can balance the power dynamics.
What is the bargaining power of buyers in the cardiac stent market in 2025?
The bargaining power of buyers is moderate. Hospitals, clinics, and healthcare systems often purchase in bulk, giving them some leverage in negotiations with suppliers. However, the high level of specialization, along with the critical nature of stent treatments, limits their ability to negotiate significantly on price.
What is the threat of substitute products or services in the cardiac stent market in 2025?
The threat of substitutes is moderate. While there are alternative treatments like coronary artery bypass grafting (CABG) and drug therapies, stents are often preferred due to their minimally invasive nature. However, advances in non-invasive treatments or newer technologies could pose a potential threat to the stent market in the future.
How intense is the rivalry among existing competitors in the cardiac stent market in 2025?
The rivalry among existing competitors is high. The market is dominated by a few large players with established brands, such as Abbott, Medtronic, and Boston Scientific. These companies compete on innovation, price, and distribution channels. The continuous need for product innovation, regulatory approvals, and market share battles drive intense competition.
Market Upstream Analysis
What are the key raw materials required in the cardiac stent market in 2025?
The key raw materials for cardiac stents include metals like stainless steel, cobalt-chromium, and platinum for durability and strength. Polymers and biodegradable materials are used for drug-eluting and bioresorbable stents. Additionally, high-grade coatings and drug materials are essential for stent performance and patient outcomes.
What are the main suppliers in the cardiac stent market in 2025?
The main suppliers in the cardiac stent market are manufacturers of raw materials, such as metal alloy producers and polymer suppliers. Companies specializing in medical-grade coatings, drug-delivery technologies, and biocompatible materials also play a critical role. Additionally, advanced equipment suppliers for stent production are important upstream players.
What are the technological advancements influencing upstream factors in the cardiac stent market in 2025?
Technological advancements in material science, such as improved biocompatible polymers and coatings for drug-eluting stents, are crucial in shaping the upstream supply chain. Innovations in bioresorbable materials and the development of 3D printing technologies are also influencing the manufacturing process. These technologies require specialized raw materials and equipment, thus affecting the upstream market.
How do regulatory and compliance standards impact upstream activities in the cardiac stent market in 2025?
Regulatory standards and compliance play a significant role in upstream activities. Suppliers must meet stringent requirements for quality control, safety, and biocompatibility, as outlined by organizations like the FDA and European Medicines Agency (EMA). This can impact sourcing, production methods, and testing, influencing lead times and costs for manufacturers.
What challenges do suppliers face in the upstream cardiac stent market in 2025?
Suppliers in the upstream cardiac stent market face challenges such as fluctuating prices for raw materials, ensuring a consistent supply of high-quality biocompatible materials, and adapting to rapidly changing technological demands. Additionally, navigating complex regulatory environments and meeting ever-tightening safety standards adds pressure on suppliers to maintain compliance without increasing costs.
Market Midstream Analysis
What are the key activities in the midstream segment of the cardiac stent market in 2025?
The key activities in the midstream segment include the manufacturing, assembly, and quality control processes of cardiac stents. This involves transforming raw materials into finished products, incorporating drug-eluting technologies, and ensuring compliance with safety and regulatory standards. Additionally, innovation in stent design, such as bioresorbable stents, will be crucial during this stage.
What role do manufacturers play in the cardiac stent market in 2025?
Manufacturers are responsible for the production, assembly, and sterilization of cardiac stents. They ensure that the stents meet the required specifications and safety standards. In 2025, they will also be focused on innovation, refining stent technologies, improving biocompatibility, and reducing production costs to meet growing market demand.
What are the challenges faced in the midstream segment of the cardiac stent market in 2025?
One key challenge in the midstream segment is maintaining high-quality standards while meeting the increasing global demand. The complexity of manufacturing drug-eluting and bioresorbable stents requires sophisticated technologies and precision. Additionally, fluctuations in raw material prices and compliance with strict regulatory requirements can complicate production processes.
How will logistics and distribution impact the midstream segment of the cardiac stent market in 2025?
Logistics and distribution will play a critical role in ensuring that cardiac stents reach healthcare providers efficiently. Manufacturers must develop effective distribution networks to handle global demand, including cold-chain logistics for sensitive products. Any disruptions in supply chains, especially during regulatory inspections or crises, could affect product availability and market growth.
What are the emerging trends in the midstream segment of the cardiac stent market in 2025?
Emerging trends in the midstream segment include the increasing adoption of automated manufacturing processes, 3D printing technologies for personalized stents, and advancements in smart stents that can provide real-time monitoring of the heart. These innovations will drive improvements in manufacturing efficiency, product customization, and patient outcomes.
Market Downstream Analysis
What are the key activities in the downstream segment of the cardiac stent market in 2025?
The key activities in the downstream segment include the distribution, marketing, and final implantation of cardiac stents. This involves delivering stents to hospitals, clinics, and healthcare providers, where they are used in medical procedures. Additionally, patient education, post-procedure monitoring, and follow-up care play an essential role in ensuring successful outcomes.
What role do healthcare providers play in the cardiac stent market in 2025?
Healthcare providers, including cardiologists, surgeons, and hospitals, are responsible for diagnosing patients with coronary artery disease, selecting appropriate stents, and performing the implantation procedures. They also monitor patients’ recovery and outcomes, which influences the adoption and demand for specific types of stents. Their feedback is crucial for product improvement and market trends.
What are the challenges faced in the downstream segment of the cardiac stent market in 2025?
Challenges in the downstream segment include ensuring timely and accurate delivery of stents to healthcare facilities and maintaining stock availability in various regions. Additionally, there may be concerns over post-procedure complications, such as stent thrombosis or restenosis, which can impact patient outcomes and hospital costs. Another challenge is the cost of stent procedures, which may be a barrier to access for some patients.
How will patient awareness and demand impact the downstream segment of the cardiac stent market in 2025?
Increasing patient awareness of cardiovascular health and the availability of advanced stent technologies will drive demand in the downstream segment. As patients become more informed about treatment options, they may seek out the most effective solutions, leading to greater adoption of newer, innovative stents. This also puts pressure on healthcare providers to offer the latest technologies to remain competitive.
What are the emerging trends in the downstream segment of the cardiac stent market in 2025?
Emerging trends include the growing shift toward minimally invasive procedures, personalized treatments based on genetic profiles, and the integration of digital health technologies for remote patient monitoring. Additionally, there is a rising trend of value-based healthcare, where stent performance, patient outcomes, and cost-effectiveness play an increasingly significant role in the decision-making process.
Chapter 1, to describe Cardiac Stent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiac Stent, with price, sales, revenue and global market share of Cardiac Stent from 2018 to 2023.
Chapter 3, the Cardiac Stent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiac Stent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cardiac Stent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiac Stent.
Chapter 14 and 15, to describe Cardiac Stent sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Cardiac Stent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cardiac Stent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Bare-metal Stent (BMS)
1.3.3 Drug-eluting Stent (DES)
1.3.4 Bioresorbable Vascular Scaffold (BVS)
1.4 Market Analysis by Application
1.4.1 Overview: Global Cardiac Stent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Angina
1.4.3 Myocardial Infarction
1.4.4 Other Disease
1.5 Global Cardiac Stent Market Size & Forecast
1.5.1 Global Cardiac Stent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cardiac Stent Sales Quantity (2018-2029)
1.5.3 Global Cardiac Stent Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Abbott Vascular
2.1.1 Abbott Vascular Details
2.1.2 Abbott Vascular Major Business
2.1.3 Abbott Vascular Cardiac Stent Product and Services
2.1.4 Abbott Vascular Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Vascular Recent Developments/Updates
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Cardiac Stent Product and Services
2.2.4 Boston Scientific Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boston Scientific Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Cardiac Stent Product and Services
2.3.4 Medtronic Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Medtronic Recent Developments/Updates
2.4 Terumo (ESSEN)
2.4.1 Terumo (ESSEN) Details
2.4.2 Terumo (ESSEN) Major Business
2.4.3 Terumo (ESSEN) Cardiac Stent Product and Services
2.4.4 Terumo (ESSEN) Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Terumo (ESSEN) Recent Developments/Updates
2.5 Lepu Medical
2.5.1 Lepu Medical Details
2.5.2 Lepu Medical Major Business
2.5.3 Lepu Medical Cardiac Stent Product and Services
2.5.4 Lepu Medical Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lepu Medical Recent Developments/Updates
2.6 MicroPort
2.6.1 MicroPort Details
2.6.2 MicroPort Major Business
2.6.3 MicroPort Cardiac Stent Product and Services
2.6.4 MicroPort Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 MicroPort Recent Developments/Updates
2.7 Biosensors
2.7.1 Biosensors Details
2.7.2 Biosensors Major Business
2.7.3 Biosensors Cardiac Stent Product and Services
2.7.4 Biosensors Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biosensors Recent Developments/Updates
2.8 B.Braun
2.8.1 B.Braun Details
2.8.2 B.Braun Major Business
2.8.3 B.Braun Cardiac Stent Product and Services
2.8.4 B.Braun Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 B.Braun Recent Developments/Updates
2.9 Atrium Medical
2.9.1 Atrium Medical Details
2.9.2 Atrium Medical Major Business
2.9.3 Atrium Medical Cardiac Stent Product and Services
2.9.4 Atrium Medical Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Atrium Medical Recent Developments/Updates
2.10 Biotronik
2.10.1 Biotronik Details
2.10.2 Biotronik Major Business
2.10.3 Biotronik Cardiac Stent Product and Services
2.10.4 Biotronik Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Biotronik Recent Developments/Updates
2.11 SINOMED
2.11.1 SINOMED Details
2.11.2 SINOMED Major Business
2.11.3 SINOMED Cardiac Stent Product and Services
2.11.4 SINOMED Cardiac Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 SINOMED Recent Developments/Updates
3 Competitive Environment: Cardiac Stent by Manufacturer
3.1 Global Cardiac Stent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cardiac Stent Revenue by Manufacturer (2018-2023)
3.3 Global Cardiac Stent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cardiac Stent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cardiac Stent Manufacturer Market Share in 2022
3.4.2 Top 6 Cardiac Stent Manufacturer Market Share in 2022
3.5 Cardiac Stent Market: Overall Company Footprint Analysis
3.5.1 Cardiac Stent Market: Region Footprint
3.5.2 Cardiac Stent Market: Company Product Type Footprint
3.5.3 Cardiac Stent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cardiac Stent Market Size by Region
4.1.1 Global Cardiac Stent Sales Quantity by Region (2018-2029)
4.1.2 Global Cardiac Stent Consumption Value by Region (2018-2029)
4.1.3 Global Cardiac Stent Average Price by Region (2018-2029)
4.2 North America Cardiac Stent Consumption Value (2018-2029)
4.3 Europe Cardiac Stent Consumption Value (2018-2029)
4.4 Asia-Pacific Cardiac Stent Consumption Value (2018-2029)
4.5 South America Cardiac Stent Consumption Value (2018-2029)
4.6 Middle East and Africa Cardiac Stent Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Cardiac Stent Sales Quantity by Type (2018-2029)
5.2 Global Cardiac Stent Consumption Value by Type (2018-2029)
5.3 Global Cardiac Stent Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Cardiac Stent Sales Quantity by Application (2018-2029)
6.2 Global Cardiac Stent Consumption Value by Application (2018-2029)
6.3 Global Cardiac Stent Average Price by Application (2018-2029)
7 North America
7.1 North America Cardiac Stent Sales Quantity by Type (2018-2029)
7.2 North America Cardiac Stent Sales Quantity by Application (2018-2029)
7.3 North America Cardiac Stent Market Size by Country
7.3.1 North America Cardiac Stent Sales Quantity by Country (2018-2029)
7.3.2 North America Cardiac Stent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Cardiac Stent Sales Quantity by Type (2018-2029)
8.2 Europe Cardiac Stent Sales Quantity by Application (2018-2029)
8.3 Europe Cardiac Stent Market Size by Country
8.3.1 Europe Cardiac Stent Sales Quantity by Country (2018-2029)
8.3.2 Europe Cardiac Stent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Cardiac Stent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cardiac Stent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cardiac Stent Market Size by Region
9.3.1 Asia-Pacific Cardiac Stent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cardiac Stent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Cardiac Stent Sales Quantity by Type (2018-2029)
10.2 South America Cardiac Stent Sales Quantity by Application (2018-2029)
10.3 South America Cardiac Stent Market Size by Country
10.3.1 South America Cardiac Stent Sales Quantity by Country (2018-2029)
10.3.2 South America Cardiac Stent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Cardiac Stent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cardiac Stent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cardiac Stent Market Size by Country
11.3.1 Middle East & Africa Cardiac Stent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cardiac Stent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Cardiac Stent Market Drivers
12.2 Cardiac Stent Market Restraints
12.3 Cardiac Stent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Cardiac Stent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cardiac Stent
13.3 Cardiac Stent Production Process
13.4 Cardiac Stent Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cardiac Stent Typical Distributors
14.3 Cardiac Stent Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Cardiac Stent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cardiac Stent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Vascular Major Business
Table 5. Abbott Vascular Cardiac Stent Product and Services
Table 6. Abbott Vascular Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Vascular Recent Developments/Updates
Table 8. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 9. Boston Scientific Major Business
Table 10. Boston Scientific Cardiac Stent Product and Services
Table 11. Boston Scientific Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boston Scientific Recent Developments/Updates
Table 13. Medtronic Basic Information, Manufacturing Base and Competitors
Table 14. Medtronic Major Business
Table 15. Medtronic Cardiac Stent Product and Services
Table 16. Medtronic Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Medtronic Recent Developments/Updates
Table 18. Terumo (ESSEN) Basic Information, Manufacturing Base and Competitors
Table 19. Terumo (ESSEN) Major Business
Table 20. Terumo (ESSEN) Cardiac Stent Product and Services
Table 21. Terumo (ESSEN) Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Terumo (ESSEN) Recent Developments/Updates
Table 23. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 24. Lepu Medical Major Business
Table 25. Lepu Medical Cardiac Stent Product and Services
Table 26. Lepu Medical Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lepu Medical Recent Developments/Updates
Table 28. MicroPort Basic Information, Manufacturing Base and Competitors
Table 29. MicroPort Major Business
Table 30. MicroPort Cardiac Stent Product and Services
Table 31. MicroPort Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. MicroPort Recent Developments/Updates
Table 33. Biosensors Basic Information, Manufacturing Base and Competitors
Table 34. Biosensors Major Business
Table 35. Biosensors Cardiac Stent Product and Services
Table 36. Biosensors Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Biosensors Recent Developments/Updates
Table 38. B.Braun Basic Information, Manufacturing Base and Competitors
Table 39. B.Braun Major Business
Table 40. B.Braun Cardiac Stent Product and Services
Table 41. B.Braun Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. B.Braun Recent Developments/Updates
Table 43. Atrium Medical Basic Information, Manufacturing Base and Competitors
Table 44. Atrium Medical Major Business
Table 45. Atrium Medical Cardiac Stent Product and Services
Table 46. Atrium Medical Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Atrium Medical Recent Developments/Updates
Table 48. Biotronik Basic Information, Manufacturing Base and Competitors
Table 49. Biotronik Major Business
Table 50. Biotronik Cardiac Stent Product and Services
Table 51. Biotronik Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Biotronik Recent Developments/Updates
Table 53. SINOMED Basic Information, Manufacturing Base and Competitors
Table 54. SINOMED Major Business
Table 55. SINOMED Cardiac Stent Product and Services
Table 56. SINOMED Cardiac Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. SINOMED Recent Developments/Updates
Table 58. Global Cardiac Stent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Cardiac Stent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Cardiac Stent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Cardiac Stent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Cardiac Stent Production Site of Key Manufacturer
Table 63. Cardiac Stent Market: Company Product Type Footprint
Table 64. Cardiac Stent Market: Company Product Application Footprint
Table 65. Cardiac Stent New Market Entrants and Barriers to Market Entry
Table 66. Cardiac Stent Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Cardiac Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Cardiac Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Cardiac Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Cardiac Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Cardiac Stent Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Cardiac Stent Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Cardiac Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Cardiac Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Cardiac Stent Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Cardiac Stent Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Cardiac Stent Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Cardiac Stent Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Cardiac Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Cardiac Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Cardiac Stent Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Cardiac Stent Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Cardiac Stent Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Cardiac Stent Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Cardiac Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Cardiac Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Cardiac Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Cardiac Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Cardiac Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Cardiac Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Cardiac Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Cardiac Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Cardiac Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Cardiac Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Cardiac Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Cardiac Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Cardiac Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Cardiac Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Cardiac Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Cardiac Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Cardiac Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Cardiac Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Cardiac Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Cardiac Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Cardiac Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Cardiac Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Cardiac Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Cardiac Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Cardiac Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Cardiac Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Cardiac Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Cardiac Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Cardiac Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Cardiac Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Cardiac Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Cardiac Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Cardiac Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Cardiac Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Cardiac Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Cardiac Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Cardiac Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Cardiac Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Cardiac Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Cardiac Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Cardiac Stent Raw Material
Table 126. Key Manufacturers of Cardiac Stent Raw Materials
Table 127. Cardiac Stent Typical Distributors
Table 128. Cardiac Stent Typical Customers
List of Figures
Figure 1. Cardiac Stent Picture
Figure 2. Global Cardiac Stent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cardiac Stent Consumption Value Market Share by Type in 2022
Figure 4. Bare-metal Stent (BMS) Examples
Figure 5. Drug-eluting Stent (DES) Examples
Figure 6. Bioresorbable Vascular Scaffold (BVS) Examples
Figure 7. Global Cardiac Stent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Cardiac Stent Consumption Value Market Share by Application in 2022
Figure 9. Angina Examples
Figure 10. Myocardial Infarction Examples
Figure 11. Other Disease Examples
Figure 12. Global Cardiac Stent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Cardiac Stent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Cardiac Stent Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Cardiac Stent Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Cardiac Stent Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Cardiac Stent Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Cardiac Stent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Cardiac Stent Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Cardiac Stent Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Cardiac Stent Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Cardiac Stent Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Cardiac Stent Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Cardiac Stent Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Cardiac Stent Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Cardiac Stent Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Cardiac Stent Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Cardiac Stent Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Cardiac Stent Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Cardiac Stent Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Cardiac Stent Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Cardiac Stent Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Cardiac Stent Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Cardiac Stent Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Cardiac Stent Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Cardiac Stent Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Cardiac Stent Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Cardiac Stent Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Cardiac Stent Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Cardiac Stent Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Cardiac Stent Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Cardiac Stent Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Cardiac Stent Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Cardiac Stent Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Cardiac Stent Consumption Value Market Share by Region (2018-2029)
Figure 54. China Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Cardiac Stent Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Cardiac Stent Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Cardiac Stent Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Cardiac Stent Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Cardiac Stent Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Cardiac Stent Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Cardiac Stent Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Cardiac Stent Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Cardiac Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Cardiac Stent Market Drivers
Figure 75. Cardiac Stent Market Restraints
Figure 76. Cardiac Stent Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Cardiac Stent in 2022
Figure 79. Manufacturing Process Analysis of Cardiac Stent
Figure 80. Cardiac Stent Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
